scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VIROL.2006.03.046 |
P698 | PubMed publication ID | 16712895 |
P50 | author | Joan Pujols | Q42593202 |
Laila Darwich | Q45382470 | ||
Ivan Díaz | Q56810275 | ||
P2093 | author name string | Mateu E | |
Pappaterra G | |||
P2860 | cites work | The molecular biology of arteriviruses | Q56897174 |
Cytokine profiles of peripheral blood mononuclear cells from pigs with postweaning multisystemic wasting syndrome in response to mitogen, superantigen or recall viral antigens | Q57207509 | ||
Strategies to control PRRS: a summary of field and research experiences | Q73504875 | ||
Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development | Q33930291 | ||
The level of virus-specific T-cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus load | Q34151395 | ||
The immune response to equine arteritis virus: potential lessons for other arteriviruses | Q35928792 | ||
Role of neutralizing antibodies in PRRSV protective immunity | Q35928806 | ||
Use of ELISPOT and ELISA to evaluate IFN-gamma, IL-10 and IL-4 responses in conventional pigs | Q40420514 | ||
Upregulation of IL-10 gene expression in porcine peripheral blood mononuclear cells by porcine reproductive and respiratory syndrome virus | Q40566308 | ||
Molecular characterization of Lelystad virus. | Q40652369 | ||
A molecular clock dates the common ancestor of European-type porcine reproductive and respiratory syndrome virus at more than 10 years before the emergence of disease | Q40678409 | ||
Slow-reacting and complement-requiring neutralizing antibody in swine infected with porcine reproductive and respiratory syndrome (PRRS) virus | Q41177883 | ||
A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera | Q41458833 | ||
Mystery swine disease in the Netherlands: The isolation of Lelystad virus | Q41677026 | ||
Examination of the selective pressures on a live PRRS vaccine virus | Q42618488 | ||
Molecular characterization of porcine reproductive and respiratory syndrome virus, a member of the arterivirus group | Q42619566 | ||
Phylogenetic analyses of the putative M (ORF 6) and N (ORF 7) genes of porcine reproductive and respiratory syndrome virus (PRRSV): implication for the existence of two genotypes of PRRSV in the U.S.A. and Europe | Q42686832 | ||
Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice | Q45049439 | ||
Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus | Q45447879 | ||
Correlation of cell-mediated immunity against porcine reproductive and respiratory syndrome virus with protection against reproductive failure in sows during outbreaks of porcine reproductive and respiratory syndrome in commercial herds | Q45462836 | ||
New insights into the genetic diversity of European porcine reproductive and respiratory syndrome virus (PRRSV). | Q45490280 | ||
Pathogenic and humoral immune responses to porcine reproductive and respiratory syndrome virus (PRRSV) are related to viral load in acute infection | Q45559476 | ||
Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy | Q45567949 | ||
Genomic characterization of virulent, attenuated, and revertant passages of a North American porcine reproductive and respiratory syndrome virus strain. | Q45658151 | ||
Parameters of Humoral and Cellular Immunity Following Vaccination of Pigs with a European Modified-Live Strain of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) | Q45710615 | ||
Upregulation of interleukin-10 gene expression in the leukocytes of pigs infected with porcine reproductive and respiratory syndrome virus | Q45718490 | ||
Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines | Q45722116 | ||
Expression of interleukin-10 and interleukin-12 in piglets experimentally infected with porcine reproductive and respiratory syndrome virus (PRRSV). | Q45722199 | ||
Gradual development of the interferon-γ response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination | Q45723769 | ||
Genetic diversity and phylogenetic analysis of glycoprotein 5 of European-type porcine reproductive and respiratory virus strains in Spain | Q45729017 | ||
Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus | Q45729116 | ||
Risk factors for infection of sow herds with porcine reproductive and respiratory syndrome (PRRS) virus | Q45733896 | ||
Elevated serum haptoglobin in pigs infected with porcine reproductive and respiratory syndrome virus | Q45746951 | ||
Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infections: correlations with pathogenicity | Q45748123 | ||
Effect on viraemia of an American and a European serotype PRRSV vaccine after challenge with European wild-type strains of the virus | Q45755668 | ||
Efficacy of an inactivated vaccine for prevention of reproductive failure induced by porcine reproductive and respiratory syndrome virus | Q45761816 | ||
Characterization of the Humoral Immune Response to Porcine Reproductive and Respiratory Syndrome (PRRS) Virus Infection | Q45788537 | ||
Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses | Q45844085 | ||
The 2b protein as a minor structural component of PRRSV. | Q47747498 | ||
Deciphering the involvement of innate immune factors in the development of the host response to PRRSV vaccination | Q47905938 | ||
Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for porcine reproductive and respiratory syndrome. | Q51685719 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | porcine reproductive and respiratory syndrome virus | Q1760147 |
porcine reproductive and respiratory syndrome | Q2275037 | ||
P304 | page(s) | 249-259 | |
P577 | publication date | 2006-05-19 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs | |
P478 | volume | 351 |
Q93048878 | A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection |
Q41450592 | A comparative study of the local cytokine response in the lungs of pigs experimentally infected with different PRRSV-1 strains: upregulation of IL-1α in highly pathogenic strain induced lesions |
Q44962786 | A modified live PRRSV vaccine and the pathogenic parent strain induce regulatory T cells in pigs naturally infected with Mycoplasma hyopneumoniae |
Q34260827 | A new modified live porcine reproductive and respiratory syndrome vaccine improves growth performance in pigs under field conditions |
Q35089195 | Anti-idiotypic antibodies reduce efficacy of the attenuated vaccine against highly pathogenic PRRSV challenge |
Q39705319 | Assessment of safety and reproductive performance after vaccination with a modified live-virus PRRS genotype 1 vaccine in pregnant sows at various stages of gestation |
Q40615914 | Attempts to enhance cross-protection against porcine reproductive and respiratory syndrome viruses using chimeric viruses containing structural genes from two antigenically distinct strains. |
Q40058547 | Attenuation of porcine reproductive and respiratory syndrome virus strain MN184 using chimeric construction with vaccine sequence |
Q35116494 | Boosting in planta production of antigens derived from the porcine reproductive and respiratory syndrome virus (PRRSV) and subsequent evaluation of their immunogenicity |
Q89518998 | Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2 |
Q37775727 | Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiology. |
Q37493297 | Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology |
Q34121223 | Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus |
Q42248007 | Characterization of homologous and heterologous adaptive immune responses in porcine reproductive and respiratory syndrome virus infection |
Q40125239 | Characterization of immune responses following homologous reinfection of pigs with European subtype 1 and 3 porcine reproductive and respiratory syndrome virus strains that differ in virulence |
Q40272313 | Comparative analysis of immune responses following experimental infection of pigs with European porcine reproductive and respiratory syndrome virus strains of differing virulence |
Q36905803 | Comparative expression of Toll-like receptors and inflammatory cytokines in pigs infected with different virulent porcine reproductive and respiratory syndrome virus isolates |
Q44808944 | Comparison of different vaccination schedules for sustaining the immune response against porcine reproductive and respiratory syndrome virus. |
Q34432119 | Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges |
Q45382031 | Cytokine expression by macrophages in the lung of pigs infected with the porcine reproductive and respiratory syndrome virus |
Q34569610 | Cytokine profiles and phenotype regulation of antigen presenting cells by genotype-I porcine reproductive and respiratory syndrome virus isolates |
Q42224953 | Cytokines transcript levels in lung and lymphoid organs during genotype 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) infection |
Q39478449 | Development of a DNA-launched replicon as a vaccine for porcine reproductive and respiratory syndrome virus. |
Q40790895 | Differences of immune responses between Tongcheng (Chinese local breed) and Large White pigs after artificial infection with highly pathogenic porcine reproductive and respiratory syndrome virus |
Q38441596 | Distinct functional enrichment of transcriptional signatures in pigs with high and low IFN-gamma responses after vaccination with a porcine reproductive and respiratory syndrome virus (PRRSV). |
Q40298624 | Effects of challenge with a virulent genotype II strain of porcine reproductive and respiratory syndrome virus on piglets vaccinated with an attenuated genotype I strain vaccine. |
Q45323989 | Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs |
Q45384517 | Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity. |
Q40973523 | Efficacy of combined vaccination against Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus in dually infected pigs. |
Q45359135 | Enhanced expression of TGFβ protein in lymphoid organs and lung, but not in serum, of pigs infected with a European field isolate of porcine reproductive and respiratory syndrome virus. |
Q40695891 | Establishing Porcine Monocyte-Derived Macrophage and Dendritic Cell Systems for Studying the Interaction with PRRSV-1. |
Q61473737 | European genotype of porcine reproductive and respiratory syndrome (PRRSV) infects monocyte-derived dendritic cells but does not induce Treg cells |
Q90437990 | Evaluation of PRRSv specific, maternally derived and induced immune response in Ingelvac PRRSFLEX EU vaccinated piglets in the presence of maternally transferred immunity |
Q37203209 | Evaluation of the Cross-Protective Efficacy of a Chimeric Porcine Reproductive and Respiratory Syndrome Virus Constructed Based on Two Field Strains. |
Q42209705 | Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge |
Q41781830 | Functional impairment of PRRSV-specific peripheral CD3+CD8high cells |
Q45384291 | GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge |
Q42260304 | Genetic and antigenic characterization of complete genomes of Type 1 Porcine Reproductive and Respiratory Syndrome viruses (PRRSV) isolated in Denmark over a period of 10 years |
Q45357815 | Gp96 enhances the immunogenicity of subunit vaccine of porcine reproductive and respiratory syndrome virus |
Q45367705 | Identification of immunodominant T-cell epitopes in membrane protein of highly pathogenic porcine reproductive and respiratory syndrome virus |
Q38668708 | Immune Control of PRRS: Lessons to be Learned and Possible Ways Forward |
Q61801298 | Immune response development after vaccination of 1-day-old naïve pigs with a Porcine Reproductive and Respiratory Syndrome 1-based modified live virus vaccine |
Q45366240 | Immune responses in piglets infected with highly pathogenic porcine reproductive and respiratory syndrome virus |
Q38971626 | Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF. |
Q82416184 | Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant |
Q45355535 | Immunohistochemical expression of IL-12, IL-10, IFN-α and IFN-γ in lymphoid organs of porcine reproductive and respiratory syndrome virus-infected pigs |
Q37934055 | Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS). |
Q38069683 | Immunopathogenesis of porcine reproductive and respiratory syndrome in the respiratory tract of pigs. |
Q40046407 | Improved Vaccine against PRRSV: Current Progress and Future Perspective |
Q45382377 | In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nucleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus |
Q59793645 | In vitro immune responses of porcine alveolar macrophages reflect host immune responses against porcine reproductive and respiratory syndrome viruses |
Q43543311 | Induction of T helper 3 regulatory cells by dendritic cells infected with porcine reproductive and respiratory syndrome virus |
Q30410415 | Interaction between innate immunity and porcine reproductive and respiratory syndrome virus |
Q44335250 | Location of T-cell epitopes in nonstructural proteins 9 and 10 of type-II porcine reproductive and respiratory syndrome virus. |
Q45353543 | Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from |
Q37775279 | Modulation of host cell responses and evasion strategies for porcine reproductive and respiratory syndrome virus |
Q40656239 | Molecular epidemiology of porcine reproductive and respiratory syndrome viruses isolated from 1991 to 2013 in Taiwan |
Q34269264 | Mycobacterium tuberculosis whole cell lysate enhances proliferation of CD8 positive lymphocytes and nitric oxide secretion in the lungs of live porcine respiratory and reproductive syndrome virus vaccinated pigs |
Q39320224 | N-linked glycosylation of GP5 of porcine reproductive and respiratory syndrome virus is critically important for virus replication in vivo |
Q30235375 | Next-generation sequencing as a tool for the study of Porcine reproductive and respiratory syndrome virus (PRRSV) macro- and micro- molecular epidemiology. |
Q40916154 | PD-L1 expression is increased in monocyte derived dendritic cells in response to porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus infections |
Q37249703 | Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus |
Q44111791 | Phenotypic and functional modulation of bone marrow-derived dendritic cells by porcine reproductive and respiratory syndrome virus |
Q34646875 | Pig immune response to general stimulus and to porcine reproductive and respiratory syndrome virus infection: a meta-analysis approach |
Q47219938 | Plant synthetic GP4 and GP5 proteins from porcine reproductive and respiratory syndrome virus elicit immune responses in pigs |
Q45352118 | Plasmids expressing porcine interferon gamma up-regulate pro-inflammatory cytokine and co-stimulatory molecule expression which are suppressed by porcine reproductive and respiratory syndrome virus |
Q30364184 | Porcine reproductive and respiratory syndrome (PRRS): an immune dysregulatory pandemic. |
Q44453997 | Porcine reproductive and respiratory syndrome virus induces CD4+CD8+CD25+Foxp3+ regulatory T cells (Tregs). |
Q39274756 | Porcine reproductive and respiratory syndrome virus induces pronounced immune modulatory responses at mucosal tissues in the parental vaccine strain VR2332 infected pigs |
Q42071929 | Porcine reproductive and respiratory syndrome virus infects mature porcine dendritic cells and up-regulates interleukin-10 production |
Q38076180 | Porcine reproductive and respiratory syndrome virus vaccines: current status and strategies to a universal vaccine |
Q38597798 | Positive effects of porcine IL-2 and IL-4 on virus-specific immune responses induced by the porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 DNA vaccine in swine |
Q40259551 | Predicted peptides from non-structural proteins of porcine reproductive and respiratory syndrome virus are able to induce IFN-γ and IL-10. |
Q35124260 | RNA-sequence analysis of primary alveolar macrophages after in vitro infection with porcine reproductive and respiratory syndrome virus strains of differing virulence |
Q42236586 | Regulation of toll-like receptors 3, 7 and 9 in porcine alveolar macrophages by different genotype 1 strains of porcine reproductive and respiratory syndrome virus. |
Q27001221 | Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? |
Q36286076 | Rescue and evaluation of a recombinant PRRSV expressing porcine Interleukin-4. |
Q28071014 | Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccination |
Q34433140 | Risk factors for porcine reproductive and respiratory syndrome virus infection and resulting challenges for effective disease surveillance. |
Q58760019 | Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region |
Q64090850 | Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against and an inactivated vaccine against and in breeding pigs |
Q40520410 | Strategies to broaden the cross-protective efficacy of vaccines against porcine reproductive and respiratory syndrome virus. |
Q36286619 | Suppression of immune responses in pigs by nonstructural protein 1 of porcine reproductive and respiratory syndrome virus |
Q45352700 | Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity |
Q35784569 | The 15N and 46R Residues of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Protein Enhance Regulatory T Lymphocytes Proliferation |
Q36888431 | The challenge of PRRS immunology. |
Q45357557 | Type 2 Porcine Reproductive and Respiratory Syndrome Virus infection mediated apoptosis in B- and T-cell areas in lymphoid organs of experimentally infected pigs. |
Q53729326 | Vaccination of piglets at 2 and 3 weeks of age with Ingelvac PRRSFLEX® EU provides protection against heterologous field challenge in the face of homologous maternally derived antibodies. |
Q37582096 | Vaccination of sows against type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) before artificial insemination protects against type 2 PRRSV challenge but does not protect against type 1 PRRSV challenge in late gestation |
Q37769862 | Vectored vaccines to protect against PRRSV. |
Search more.